The usefulness of brain amyloid image using flutemetamol and glucose metabolism for the neurogenerative disease - The usefulness of brain amyloid image using flutemetamol and glucose metabolism for the neurogenerative disease

Itoh Yoshiaki0 个研究点目标入组 100 人开始时间: 2019年3月27日最近更新: 2023年10月17日

试验速览

暂无简介。

•Healthy control
•1. Ages 20 and over
•2. Written informed consent
•1. Diagnosed as neurogenerative disease related to tau protain (Alzheimer's disease, Dementia with Lewy Bodies, Frontotemporal lobar degeneration, Parkinson's syndrome) by clinical symptom, Neurological findings, MRI and cognitive function test.
•2. Written informed consent

•Healthy control
•1. A person who has brain disease (Parkinson's disease, dementia related disease, etc.)
•2. A person who has serious disease complications or who has a history of these and who is considered as inappropriate by researcher.
•3. Pregnant, unwilling to practice contraception during the study, or lactating female.
•4. Participated in nuclear medicine examination within 6 months.
•5. Claustrophobia
•6. Judged inappropriate as subject by investigator.
•1. A person who is complicated by brain disease other than the disease concerned (including an obvious history of cerebral infarction) and taking a drug that effects on the central nervous system
•2. A person who has serious disease complications or has a history of these and is judged to be unsuitable as a subject of this research by a doctor who is a researcher etc.
•3. Pregnant, unwilling to practice contraception during the study, or lactating female.
•4. Participated in nuclear medicine examination within 6 months.
•5. Claustrophobia
•6. Judged inappropriate as subject by investigator.

发起方

Itoh Yoshiaki